SLDB (STOCKS)
Solid Biosciences Inc. Common Stock
$8.449300
+0.429300 (+5.35%)
Prev close: $8.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alexander Gery Cumbo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $826.00M
- Employees
- 100
- P/E (TTM)
- -3.97
- P/B (TTM)
- 3.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.53 | $-0.53 | -0.0008 | -0.15% |
|
Sep 2025 (Q3)
|
$-0.48 | $-0.45 | -0.0325 | -7.26% |
|
Jun 2025 (Q2)
|
$-0.42 | $-0.51 | +0.0942 | +18.32% |
|
Mar 2025 (Q1)
|
$-0.59 | $-0.57 | -0.0231 | -4.07% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.88M |
| Operating Expenses | $179.21M |
| Depreciation and Amortization | $1.64M |
| Research and Development | $140.33M |
| Other Operating Expenses | $37.25M |
| Operating Income/Loss | -$179.21M |
| Income/Loss From Continuing Operations After Tax | -$174.20M |
| Income/Loss From Continuing Operations Before Tax | -$174.20M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$174.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$174.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$174.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.99 |
| Diluted Earnings Per Share | -$1.99 |
| Basic Average Shares | 87,504,631 |
| Diluted Average Shares | 87,504,631 |
| Assets | $232.54M |
| Current Assets | $205.46M |
| Cash | $187.90M |
| Other Current Assets | $17.56M |
| Noncurrent Assets | $27.08M |
| Fixed Assets | $4.17M |
| Other Non-current Assets | $22.92M |
| Liabilities | $52.53M |
| Current Liabilities | $33.47M |
| Accounts Payable | $3.22M |
| Other Current Liabilities | $30.25M |
| Noncurrent Liabilities | $19.06M |
| Equity | $180.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $180.01M |
| Liabilities And Equity | $232.54M |
| Net Cash Flow From Operating Activities | -$156.29M |
| Net Cash Flow From Operating Activities, Continuing | -$156.29M |
| Net Cash Flow From Investing Activities | -$58.45M |
| Net Cash Flow From Investing Activities, Continuing | -$58.45M |
| Net Cash Flow From Financing Activities | $194.45M |
| Net Cash Flow From Financing Activities, Continuing | $194.45M |
| Net Cash Flow | -$20.30M |
| Net Cash Flow, Continuing | -$20.30M |
| Comprehensive Income/Loss | -$174.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$174.32M |
| Other Comprehensive Income/Loss | $5.00K |